Abstract
Cellular plasticity enables cells to dynamically adapt to environmental changes by altering their phenotype. This plasticity plays a crucial role in tissue repair and regeneration and contributes to pathological processes such as cancer metastasis. Advances in single‐cell omics have significantly advanced the study of cellular states and provided new opportunities for accurate cell classification and uncovering cellular transitions. In this perspective, we emphasize integrating chromatin accessibility data and extrinsic factors, such as microenvironmental cues, with single‐cell transcriptomic data to develop holistic models for identifying plastic cell states. Additionally, coupling artificial intelligence with single‐cell omics offers transformative potential to address existing challenges and fill gaps in identifying and characterizing plastic cells. We envision the development of a universal plasticity metric, a standardized metric for quantifying cellular plasticity. This metric would enable consistent measurement across diverse studies, creating a unified framework that bridges fields such as developmental biology, cancer research, and regenerative medicine. Fostering innovative approaches to identifying and analyzing cellular plasticity promises not only to deepen our understanding of cellular plasticity but also to accelerate therapeutic advancements, paving the way for novel precision medicine strategies to treat complex diseases such as cancer.
Keywords: cell plasticity, epigenetics, foundation models, single‐cell omics
1. INTRODUCTION
Cellular plasticity enables cells to adapt to environmental changes by altering their phenotype without genetic modification [1, 2]. This property is fundamental to processes such as tissue repair, regeneration, and development [3, 4]. At the same time, it also plays a pivotal role in pathological contexts, such as cancer metastasis, where cells undergo an epithelial‐to‐mesenchymal transition (EMT), enhancing their motility and invasiveness to spread across the body [5, 6].
Cellular plasticity manifests through two principal mechanisms: dedifferentiation and transdifferentiation [1, 2]. Dedifferentiation refers to the reversion of specialized cells to a progenitor or stem‐like state. This capability is crucial in tissue regeneration, where cells lose their differentiated traits to participate in tissue repair and replenishment [1, 2]. A profound example of this process is the generation of induced pluripotent stem cells, where differentiated cells are reprogrammed to a pluripotent state [7], showcasing the immense potential for regenerative medicine and personalized therapies. Transdifferentiation, on the other hand, involves the direct conversion of one differentiated cell type into another [1, 2]. A classic illustration is the EMT process, which is not only essential for embryonic development (type 1 EMT) but also implicated in fibrosis (type 2 EMT) and cancer metastasis (type 3 EMT) [8]. These dynamic transitions demonstrate the dual nature of plasticity as a force for both physiological and pathological change.
2. CAPTURING CELLULAR PLASTICITY THROUGH INTEGRATIVE SINGLE‐CELL OMICS APPROACHES
Before the emergence of single‐cell omics technologies, the study of cellular plasticity relied on relatively coarse and indirect methods. Early investigations employed histological staining and microscopy to observe changes in cellular structure and morphology [9], but these approaches provided no insights into the molecular mechanisms driving plasticity. Bulk omics studies offered a broader view by identifying molecular mechanisms regulating cellular plasticity [10]; however, they lacked the resolution to capture these processes at the single‐cell level. Functional assays, such as lineage tracing, were pivotal in observing cellular plasticity during differentiation or regeneration, providing direct evidence of cellular transitions over time [11]. Nonetheless, these methods were labor‐intensive and lacked molecular granularity, failing to elucidate the underlying gene regulatory networks (GRNs). Single‐cell omics have revolutionized the study of cellular plasticity by enabling molecular analysis at the resolution of individual cells. In contrast to bulk approaches, single‐cell technologies enable the identification of cell‐to‐cell variability and the detection of transient cellular states that underlie plasticity [12, 13]. Among these, single‐cell RNA sequencing (scRNA‐seq) has been transformative, providing unparalleled insights into cellular states and developmental trajectories [12, 14, 15, 16, 17]. In addition to its high resolution, single‐cell omics have uncovered key aspects of cancer cell plasticity. For example, hybrid cell states, such as hybrid EMT, have been identified using single‐cell data. Moreover, single‐cell studies have provided valuable opportunities to investigate cancer cell evolution, offering a deeper understanding of tumor heterogeneity and progression [18, 19, 20]. Despite these advances, a significant gap remains in current single‐cell omics approaches for accurately identifying plastic cell states, highlighting the need for more precise computational methods to fully capture the dynamic nature of cellular plasticity (Box 1).
BOX 1 Gaps in current approaches.
1.
Limited multimodal integration: Current methods often focus heavily on single data transcriptomic data without fully integrating multiomics (e.g., scRNA‐seq, scATAC‐seq, and spatial data) to provide a comprehensive view of plasticity.
Static representations: Many approaches use static snapshots of cellular states, failing to capture the dynamic transitions that characterize cell plasticity over time.
Intrinsic bias in models and complexity of extrinsic influences: Cellular plasticity is shaped by extrinsic factors such as the microenvironment, cytokines, and cell–cell interactions, which are difficult to model or measure comprehensively. Therefore, many models focus solely on intrinsic properties, ignoring the impact of external factors such as extra signaling pathways or cell–cell interaction.
Lack of standardized metrics: The absence of standardized metrics for cellular plasticity hinders cross‐study comparisons and reproducibility.
Underutilization of chromatin data: Chromatin accessibility which provides key insights into regulatory plasticity, is underexplored in many plasticity models.
While single‐cell omics have provided transformative insights into cellular plasticity, current approaches predominantly focus on transcriptomic data [13, 21, 22], often neglecting chromatin accessibility. Epigenetic regulation is fundamental to modulating chromatin accessibility and transcriptional activity through modifications of DNA and histone markers [23]. Epigenetic regulations play an equally pivotal role in modulating cellular plasticity and warrant deeper exploration. Stem cells are characterized by their remarkable plasticity, which is facilitated by an “open” chromatin state that enables dynamic transcriptional responses to environmental stimuli. During differentiation, this chromatin landscape transitions to a more “closed” state, thereby stabilizing the cell’s commitment to a specific lineage [24, 25]. Furthermore, the EMT is associated with alterations in chromatin accessibility at EMT‐related genes [26, 27], highlighting the interplay between epigenetic mechanisms and cellular transitions. Environmental factors, such as chronic cigarette smoke, have also been shown to induce epigenetic changes in human bronchial epithelial cells, creating a permissive state for oncogenic transformation [28]. Collectively, these findings underscore the central role of epigenetic modifications in regulating cellular plasticity.
In addition to the intrinsic role of epigenetic modifications in driving cellular plasticity, this phenomenon arises from a complex interplay between intrinsic factors, such as the genome, epigenome, and intracellular signaling pathways, and extrinsic influences such as cell–cell interactions, cytokine signaling, and, the extracellular microenvironment [29, 30]. This dynamic interaction underscores the multifaceted nature of cellular plasticity and the limitations of current approaches in fully capturing its complexity (Box 1). For instance, the presence of senescent cells has been shown to promote cellular plasticity through a phenomenon known as senescence‐associated plasticity [29, 30]. The secretome of senescent cells, which includes components of the senescence‐associated secretory phenotype, has been implicated in mediating processes such as EMT within the tumor microenvironment [31, 32]. The advancement of spatial transcriptomic technologies [33] now enables the study of how these extrinsic factors orchestrate cellular plasticity with greater spatial and contextual resolution.
Given the multifaceted nature of cellular plasticity shaped by intrinsic and extrinsic factors, advanced integrative approaches are essential to bridge this complexity. Therefore, adopting integrative multiomics approaches, particularly the combination of scRNA‐seq with single‐cell ATAC sequencing (scATAC‐seq) and spatial transcriptomic, offers a promising strategy to capture cellular plasticity more holistically. Furthermore, leveraging omics data to infer extrinsic factors such as cell–cell communication, cellular spatial location, and environmental cues provides deeper insights into how these interactions shape cellular behavior. These insights underscore the critical need for models that integrate both intrinsic and extrinsic determinants to accurately characterize and predict plasticity states.
3. HARNESSING SINGLE‐CELL OMICS AND AI TO UNLOCK CELLULAR PLASTICITY
AI‐driven approaches leveraging single‐cell omic data have been employed to quantify cellular plasticity, offering valuable insights into its dynamics. However, current methods remain limited in their ability to generalize across biological contexts. For instance, scBlender has been used to measure the plasticity of basal–luminal mixed lineages following antiandrogen receptor (enzalutamide) treatment in prostate cancer [34], while another approach assesses plasticity after the induction of a KRAS mutation during pancreatic tumorigenesis [35]. Although these methods provide valuable insights, they rely on classification‐based approaches that use uncertainty in predictions as a proxy for plasticity [34, 35]. Moreover, they are often dataset‐specific, making it difficult to generalize across different biological contexts. Thus, more generalized approaches are needed to systematically quantify cellular plasticity across diverse conditions (Box 1).
The development of universal single‐cell atlases for transcriptomic and chromatin accessibility data has facilitated the emergence of foundational models for single‐cell omics [36, 37, 38, 39, 40, 41]. These AI‐driven models hold transformative potential in decoding cellular states and enhancing cell classification [39, 42, 43, 44]. Coupling AI with single‐cell omics can address critical gaps in current approaches to measuring and detecting plastic cells (Box 1). For instance, AI‐based models enable robust multimodal integration, seamlessly combining data from scRNA‐seq, scATAC‐seq, and spatial transcriptomics to uncover intricate relationships between gene expression, chromatin states, and spatial localization [45, 46]. Interpretable AI models in sc‐omic data enable feature selection by identifying biologically relevant patterns [47]. A key application is inferring GRNs from scRNA‐seq. These models uncover regulatory relationships by learning data structures and capturing context‐specific gene interactions [46]. Additionally, single‐cell omic foundational models provide efficient integration of datasets across different species [40]. For example, tools such as SATURN have advanced the integration of cross‐species scRNA‐seq data by linking gene expression profiles with protein embeddings. This tool has facilitated the creation of universal cell embeddings, enabling the identification of both conserved and species‐specific cell types across diverse datasets [40]. Moreover, AI algorithms can predict cellular state trajectories and model dynamic processes, thus overcoming the limitations of static representations inherent in single‐cell omics data [48]. Furthermore, AI‐powered spatial tools facilitate in‐depth exploration of cellular spatial organization, offering a holistic view of cellular and tissue properties critical for understanding cellular plasticity [45].
Interestingly, the concept of AI virtual cells (AIVC) has been proposed [49]. These data‐driven models aim to decode cellular behaviors and dynamics by constructing universal representations (URs) that integrate biological data across molecular, cellular, and multicellular scales [49]. URs are envisioned to be generated through the integration of multimodal measurements, including single‐cell omic data (scRNA‐seq and scATAC‐seq), spatial transcriptomics, and fluorescence microscopy. By leveraging these universal frameworks, AIVC models hold the potential to accurately simulate cellular dynamics and state transitions, whether naturally occurring (e.g., differentiation) or induced by external factors such as drug treatments [49].
Building on these advancements, we envision the development of a universal plasticity metric (UPM) using foundational models to standardize the measurement of cellular plasticity across species and studies. This metric would harmonize research across diverse fields such as developmental biology, cancer research, and regenerative medicine, providing a consistent framework for evaluating plasticity. Critically, UPM could reveal conserved regulatory mechanisms underlying plasticity, opening new avenues for therapeutic innovation. Furthermore, integrating UPM with in‐silico perturbations could help identify genes that modulate cellular plasticity, either enhancing or suppressing it. Harnessing this knowledge would enable the reprogramming of cells into desired states, offering transformative potential for therapies targeting degenerative diseases and injuries.
4. FUTURE DIRECTIONS
The integration of AI with single‐cell omics technologies presents exciting opportunities to address longstanding challenges in understanding cellular plasticity. A key future direction lies in the development of robust multimodal frameworks that can seamlessly integrate transcriptomic, epigenomic, spatial transcriptomic, and imaging data. Such AI‐powered platforms will enable researchers to decode the intricate interplay between intrinsic factors, such as chromatin accessibility, and extrinsic influences, such as microenvironmental cues and cell–cell interactions. Alongside this, the establishment of a UPM will provide a standardized and reproducible framework for quantifying cellular plasticity across studies and species. This metric will harmonize research methodologies, facilitate cross‐species comparisons, and reveal conserved regulatory mechanisms driving plasticity. Generating UPM would require integrating multiple data modalities, introducing different computational challenges [50, 51]. Each emerging modality presents unique hurdles, from low‐level processing, quality control, and normalization to downstream analysis and biological interpretation. A key challenge in single‐cell multimodal analysis is the development of efficient computational strategies for integrating diverse data types [50]. As single‐cell datasets continue to expand, the need for robust and scalable analytical tools becomes increasingly critical to effectively process and interpret large complex datasets [50, 52].
Building on the potential of AI‐powered platforms and standardized metrics for cellular plasticity, the integration of patient‐derived omics data with advanced AI models extends these innovations into the realm of precision medicine. Researchers can uncover personalized plasticity‐related pathways, paving the way for targeted interventions. Open‐source AI frameworks, such as BioChatter, enhance reproducibility and adaptability in biomedical research by integrating large language models for scalable and efficient single‐cell omics analysis [53]. However, the use of AI in this context raises ethical concerns, as biased datasets may produce discriminatory outcomes, exacerbating health disparities. Ensuring fairness and transparency requires interpretable models, transparent decision‐making, and regulatory oversight [54]. Addressing these challenges will enhance trust and reliability, allowing AI‐driven single‐cell omics to advance our understanding of cellular plasticity while accelerating the development of innovative therapies for complex diseases, including cancer and tissue fibrosis.
In conclusion, the integration of single‐cell omics, advanced AI, and foundational models represents a paradigm shift in the study of cellular biology. These cutting‐edge tools would significantly enhance our ability to understand cellular plasticity, offering unprecedented insights into the dynamic and multifaceted nature of cellular states. By addressing critical gaps in current methodologies, these technologies open new avenues for targeted therapeutic interventions, enabling the precise manipulation of cellular behavior. With these transformative advancements, we are poised to unravel the complexities of cellular plasticity and translate these insights into groundbreaking scientific discoveries and medical innovations.
AUTHOR CONTRIBUTIONS
Ahmed Ghobashi: Writing—original draft; writing—review and editing. Qin Ma: Funding acquisition; writing—review and editing.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
ACKNOWLEDGMENTS
This work was supported by TriState SenNet (Grant No. U54AG075931) and the Pelotonia Institute of Immuno‐Oncology (PIIO).
Ghobashi A, Ma Q. Perspectives on integrating artificial intelligence and single‐cell omics for cellular plasticity research. Quantitative Biology. 2025;e70004. 10.1002/qub2.70004
DATA AVAILABILITY STATEMENT
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
REFERENCES
- 1. Tata A, Chow RD, Tata PR. Epithelial cell plasticity: breaking boundaries and changing landscapes. EMBO Rep. 2021;22(7):e51921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Qin X, Tape CJ. Functional analysis of cell plasticity using single‐cell technologies. Trends Cell Biol. 2024;34(10):854–864. [DOI] [PubMed] [Google Scholar]
- 3. Adkins‐Threats M, Mills JC. Cell plasticity in regeneration in the stomach and beyond. Curr Opin Genet Dev. 2022;75:101948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Jessen KR, Mirsky R, Arthur‐Farraj P. The role of cell plasticity in tissue repair: adaptive cellular reprogramming. Dev Cell. 2015;34(6):613–620. [DOI] [PubMed] [Google Scholar]
- 5. Chaffer CL, San JBP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35(4):645–654. [DOI] [PubMed] [Google Scholar]
- 6. Ye X, Weinberg RA. Epithelial‐mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 2015;25(11):675–686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Cerneckis J, Cai H, Shi Y. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal Transduct Target Ther. 2024;9(1):112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Kalluri R, Weinberg RA. The basics of epithelial‐mesenchymal transition. J Clin Invest. 2009;119(6):1420–1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Sequist LV, Waltman BA, Dias‐Santagata D, Digumarthy S, Turke AB, Fidias P, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011;3(75):75ra26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Sun L, Burnett J, Gasparyan M, Xu F, Jiang H, Lin CC, et al. Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN‐deficient trastuzumab‐resistant breast cancer. Oncotarget. 2016;7(32):51408–51422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Kretzschmar K, Watt FM. Lineage tracing. Cell. 2012;148(1–2):33–45. [DOI] [PubMed] [Google Scholar]
- 12. Lange M, Bergen V, Klein M, Setty M, Reuter B, Bakhti M, et al. CellRank for directed single‐cell fate mapping. Nat Methods. 2022;19(2):159–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Zhou P, Wang S, Li T, Nie Q. Dissecting transition cells from single‐cell transcriptome data through multiscale stochastic dynamics. Nat Commun. 2021;12(1):5609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Saelens W, Cannoodt R, Todorov H, Saeys Y. A comparison of single‐cell trajectory inference methods. Nat Biotechnol. 2019;37(5):547–554. [DOI] [PubMed] [Google Scholar]
- 15. Li J, Pan X, Yuan Y, Shen HB. TFvelo: gene regulation inspired RNA velocity estimation. Nat Commun. 2024;15(1):1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Bergen V, Lange M, Peidli S, Wolf FA, Theis FJ. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat Biotechnol. 2020;38(12):1408–1414. [DOI] [PubMed] [Google Scholar]
- 17. Schiebinger G, Shu J, Tabaka M, Cleary B, Subramanian V, Solomon A, et al. Optimal‐transport analysis of single‐cell gene expression identifies developmental trajectories in reprogramming. Cell. 2019;176(4):928–943.e22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Pan D, Jia D. Application of single‐cell multi‐omics in dissecting cancer cell plasticity and tumor heterogeneity. Front Mol Biosci. 2021;8:757024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Marjanovic ND, Hofree M, Chan JE, Canner D, Wu K, Trakala M, et al. Emergence of a high‐plasticity cell state during lung cancer evolution. Cancer Cell. 2020;38(2):229–246.e13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Malagoli TG, Wiecek AJ, Withnell E, Secrier M. Genomic and microenvironmental heterogeneity shaping epithelial‐to‐mesenchymal trajectories in cancer. Nat Commun. 2023;14(1):789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Kong W, Fu YC, Holloway EM, Garipler G, Yang X, Mazzoni EO, et al. Capybara: a computational tool to measure cell identity and fate transitions. Cell Stem Cell. 2022;29(4):635–649.e11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kang M, Armenteros JJA, Gulati GS, Gleyzer R, Avagyan S, Brown EL, et al. Mapping single‐cell developmental potential in health and disease with interpretable deep learning. 2024. Preprint at bioRxiv: 2024.03.19.585637.
- 23. Klemm SL, Shipony Z, Greenleaf WJ. Chromatin accessibility and the regulatory epigenome. Nat Rev Genet. 2019;20(4):207–220. [DOI] [PubMed] [Google Scholar]
- 24. Gaspar‐Maia A, Alajem A, Meshorer E, Ramalho‐Santos M. Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol. 2011;12(1):36–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Martin EW, Rodriguez YBA, Reggiardo RE, Worthington AK, Mattingly CS, Poscablo DM, et al. Dynamics of chromatin accessibility during hematopoietic stem cell differentiation into progressively lineage‐committed progeny. Stem Cells. 2023;41(5):520–539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Ghobashi AH, Kimani JW, Ladaika CA, O'Hagan HM. PTEN depletion reduces H3K27me3 levels to promote epithelial‐to‐mesenchymal transition in epithelial colorectal cancer cells. PLoS One. 2024;19(11):e0313769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Sun L, Fang J. Epigenetic regulation of epithelial‐mesenchymal transition. Cell Mol Life Sci. 2016;73(23):4493–4515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Vaz M, Hwang SY, Kagiampakis I, Phallen J, Patil A, O'Hagan HM , et al. Chronic cigarette smoke‐induced epigenomic changes precede sensitization of bronchial epithelial cells to single‐step transformation by KRAS mutations. Cancer Cell. 2017;32(3):360–376.e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Cordani M, Dando I, Ambrosini G, Gonzalez‐Menendez P. Signaling, cancer cell plasticity, and intratumor heterogeneity. Cell Commun Signal. 2024;22(1):255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379(6632):eaaw3835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Ring NAR, Valdivieso K, Grillari J, Redl H, Ogrodnik M. The role of senescence in cellular plasticity: lessons from regeneration and development and implications for age‐related diseases. Dev Cell. 2022;57(9):1083–1101. [DOI] [PubMed] [Google Scholar]
- 32. Laberge RM, Awad P, Campisi J, Desprez PY. Epithelial‐mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron. 2012;5(1):39–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Marx V. Method of the Year: spatially resolved transcriptomics. Nat Methods. 2021;18(1):9–14. [DOI] [PubMed] [Google Scholar]
- 34. Chan JM, Zaidi S, Love JR, Zhao JL, Setty M, Wadosky KM, et al. Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling. Science. 2022;377(6611):1180–1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Burdziak C, Alonso‐Curbelo D, Walle T, Reyes J, Barriga FM, Haviv D, et al. Epigenetic plasticity cooperates with cell‐cell interactions to direct pancreatic tumorigenesis. Science. 2023;380(6645):eadd5327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Zhang K, Hocker JD, Miller M, Hou X, Chiou J, Poirion OB, et al. A single‐cell atlas of chromatin accessibility in the human genome. Cell. 2021;184(24):5985–6001.e19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Heimberg G, Kuo T, DePianto DJ, Salem O, Heigl T, Diamant N, et al. A cell atlas foundation model for scalable search of similar human cells. Nature. 2024;638(8052):1085–1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Tabula SC, Jones RC, Karkanias J, Krasnow MA, Pisco AO, Quake SR, et al. The Tabula Sapiens: a multiple‐organ, single‐cell transcriptomic atlas of humans. Science. 2022;376(6594):eabl4896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Theodoris CV, Xiao L, Chopra A, Chaffin MD, Al Sayed ZR, Hill MC , et al. Transfer learning enables predictions in network biology. Nature. 2023;618(7965):616–624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Rosen Y, Brbic M, Roohani Y, Swanson K, Li Z, Leskovec J. Toward universal cell embeddings: integrating single‐cell RNA‐seq datasets across species with SATURN. Nat Methods. 2024;21(8):1492–1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Ma Q, Jiang Y, Cheng H, Xu D. Harnessing the deep learning power of foundation models in single‐cell omics. Nat Rev Mol Cell Biol. 2024;25(8):593–594. [DOI] [PubMed] [Google Scholar]
- 42. Wang X, Duan M, Li J, Ma A, Xin G, Xu D, et al. MarsGT: multi‐omics analysis for rare population inference using single‐cell graph transformer. Nat Commun. 2024;15(1):338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Nasir N, Alshabi M, Al‐Yateem N, Rahman SA, Arsyad Subu M, Hijazi HH, et al. Review of machine learning advancements for single‐cell analysis. In: 2023 IEEE 47th annual computers, software, and applications conference (COMPSAC); 2023. p. 1383–1387. [Google Scholar]
- 44. Ma Q, Xu D. Deep learning shapes single‐cell data analysis. Nat Rev Mol Cell Biol. 2022;23(5):303–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Long Y, Ang KS, Sethi R, Liao S, Heng Y, van Olst L, et al. Deciphering spatial domains from spatial multi‐omics with SpatialGlue. Nat Methods. 2024;21(9):1658–1667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Ma A, Wang X, Li J, Wang C, Xiao T, Liu Y, et al. Single‐cell biological network inference using a heterogeneous graph transformer. Nat Commun. 2023;14(1):964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Wagle MM, Long S, Chen C, Liu C, Yang P. Interpretable deep learning in single‐cell omics. Bioinformatics. 2024;40(6):btae374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Huang J, Wolf G, Van Dijk D, Krishnaswamy S, editors. Trajectorynet: a dynamic optimal transport network for modeling cellular dynamics. International conference on machine learning. PMLR; 2020. [PMC free article] [PubMed] [Google Scholar]
- 49. Bunne C, Roohani Y, Rosen Y, Gupta A, Zhang X, Roed M, et al. How to build the virtual cell with artificial intelligence: priorities and opportunities. 2024. Preprint at arXiv:240911654. [DOI] [PMC free article] [PubMed]
- 50. Argelaguet R, Cuomo ASE, Stegle O, Marioni JC. Computational principles and challenges in single‐cell data integration. Nat Biotechnol. 2021;39(10):1202–1215. [DOI] [PubMed] [Google Scholar]
- 51. Lahnemann D, Koster J, Szczurek E, McCarthy DJ, Hicks SC, Robinson MD, et al. Eleven grand challenges in single‐cell data science. Genome Biol. 2020;21(1):31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Angerer P, Simon L, Tritschler S, Wolf FA, Fischer D, Theis FJ. Single cells make big data: new challenges and opportunities in transcriptomics. Curr Opin Syst Biol. 2017;4:85–91. [Google Scholar]
- 53. Lobentanzer S, Feng S, Bruderer N, Maier A, Díaz AG, Strange A, et al. A platform for the biomedical application of large language models. Nat Biotechnol. 2025;43(2):166–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Ning Y, Teixayavong S, Shang Y, Savulescu J, Nagaraj V, Miao D , et al. Generative artificial intelligence and ethical considerations in health care: a scoping review and ethics checklist. Lancet Digit Health. 2024;6(11):e848–e856. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
